|
CH602664A5
(en)
|
1973-06-14 |
1978-07-31 |
Sandoz Ag |
2-Tert. amino-alkylamino-pyrimidine derivs.
|
|
ZA835878B
(en)
*
|
1982-08-23 |
1985-03-27 |
Warner Lambert Co |
Cardiotonic agents
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
DE4425616A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Basf Ag |
Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
|
|
CA2258949C
(en)
|
1996-07-01 |
2008-05-06 |
Reddy-Cheminor, Inc. |
Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
CA2416248A1
(en)
|
2000-07-18 |
2002-01-24 |
Neurogen Corporation |
5-substituted 2-aryl-4-pyrimidinones
|
|
TW200300349A
(en)
|
2001-11-19 |
2003-06-01 |
Sankyo Co |
A 4-oxoqinoline derivative
|
|
RU2004135554A
(ru)
|
2002-05-09 |
2006-01-20 |
Цитокинетикс, Инк. (Us) |
Пиримидиноны, композиции на их основе и способы их использования
|
|
EP1509507A4
(en)
|
2002-05-23 |
2006-09-13 |
Merck & Co Inc |
INHIBITORS OF MITOTIC KINESINE
|
|
JP2004339159A
(ja)
|
2003-05-16 |
2004-12-02 |
Sankyo Co Ltd |
４−オキソキノリン誘導体を含有する医薬組成物
|
|
EP1699777B1
(en)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2005041888A2
(en)
|
2003-11-03 |
2005-05-12 |
Cytokinetics, Inc. |
Pyrimidin-4-one compounds, compositions and methods
|
|
US7625912B2
(en)
|
2003-12-19 |
2009-12-01 |
Merck & Co. Inc |
Mitotic kinesin inhibitors
|
|
WO2007033196A1
(en)
|
2005-09-14 |
2007-03-22 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
WO2007037543A1
(ja)
|
2005-09-29 |
2007-04-05 |
Banyu Pharmaceutical Co., Ltd. |
ビアリールアミド誘導体
|
|
KR20080080584A
(ko)
|
2005-11-30 |
2008-09-04 |
버텍스 파마슈티칼스 인코포레이티드 |
ｃ-Ｍｅｔ의 억제제 및 이의 용도
|
|
WO2007124397A2
(en)
|
2006-04-21 |
2007-11-01 |
Trustees Of Boston University |
Ionic viscoelastics and viscoelastic salts
|
|
JP2007308441A
(ja)
*
|
2006-05-22 |
2007-11-29 |
Sumitomo Chemical Co Ltd |
含複素環化合物及びその用途
|
|
WO2008052861A2
(de)
|
2006-10-10 |
2008-05-08 |
Proionic Production Of Ionic Substances Gmbh & Co Keg |
Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten
|
|
EP2079707B1
(de)
|
2006-10-10 |
2014-12-03 |
proionic GmbH & Co KG |
Verfahren zur umsetzung von 1,3-hetero-aromatischen 2-carboxylaten mit wasser
|
|
TW200845994A
(en)
|
2007-01-12 |
2008-12-01 |
Smithkline Beecham Corp |
N-substituted glycine derivatives: prolyl hydroxylase inhibitors
|
|
MX2009008531A
(es)
|
2007-02-16 |
2009-08-26 |
Amgen Inc |
Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
US20110253929A1
(en)
|
2008-12-22 |
2011-10-20 |
Basf Se |
Mixtures of hydrophobic and hydrophilic ionic liquids and use thereof in liquid ring compressors
|
|
EP2432776B1
(en)
|
2009-05-21 |
2019-09-11 |
Universite Laval |
Methyl sulfanyl pyrimidines useful as antiinflammatories, analgesics, and antiepileptics
|
|
JP6075621B2
(ja)
|
2010-08-10 |
2017-02-08 |
塩野義製薬株式会社 |
新規複素環誘導体およびそれらを含有する医薬組成物
|
|
EP2714698B1
(en)
|
2011-05-31 |
2016-11-09 |
Merck Patent GmbH |
Compounds containing hydrido-tricyano-borate anions
|
|
KR20140039242A
(ko)
|
2011-05-31 |
2014-04-01 |
메르크 파텐트 게엠베하 |
전해질 제형
|
|
US20140005181A1
(en)
*
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
|
WO2014004676A1
(en)
|
2012-06-26 |
2014-01-03 |
Ironwood Pharmaceuticals, Inc. |
Use of faah inhibitors as neuroprotective agents in the cns
|
|
WO2014044738A1
(en)
*
|
2012-09-21 |
2014-03-27 |
Sanofi |
Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators
|
|
DE102012021452A1
(de)
|
2012-10-31 |
2014-04-30 |
Merck Patent Gmbh |
Salze mit Trihydroperfluoralkoxybutansulfonat- oder Trihydroperfluoralkoxypropansulfonat-Anion
|
|
WO2014160185A2
(en)
|
2013-03-14 |
2014-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
|
DK3013813T3
(da)
|
2013-06-27 |
2019-06-03 |
Pfizer |
Heteroaromatiske forbindelser og anvendelse deraf som dopamin-d1-ligander
|
|
WO2014207100A1
(en)
|
2013-06-27 |
2014-12-31 |
Basf Se |
A process for coating paper with cellulose using a solution containing cellulose
|
|
KR102339016B1
(ko)
|
2013-11-29 |
2021-12-14 |
프로이오닉 게엠베하 |
마이크로파 조사에 의한 접착제 경화 방법
|
|
US10570128B2
(en)
|
2014-05-28 |
2020-02-25 |
Sanford Burnham Prebys Medical Discovery Institute |
Agonists of the apelin receptor and methods of use thereof
|
|
MX387055B
(es)
*
|
2014-06-06 |
2025-03-19 |
Res Triangle Inst |
Agonistas del receptor de apelina (apj) y usos de los mismos.
|
|
WO2016074757A1
(de)
|
2014-11-11 |
2016-05-19 |
Merck Patent Gmbh |
Verfahren zur herstellung von mono- und bis(perfluoralkyl)fluorophosphatsalzen und deren säuren
|
|
US10774051B2
(en)
|
2015-04-24 |
2020-09-15 |
Shionogi & Co., Ltd. |
6-membered heterocyclic derivatives and pharmaceutical composition comprising the same
|
|
HUE050317T2
(hu)
|
2015-05-20 |
2020-11-30 |
Amgen Inc |
APJ receptor triazol agonistái
|
|
PL3303330T3
(pl)
|
2015-06-03 |
2019-10-31 |
Bristol Myers Squibb Co |
Agoniści 4 - hydroksy - 3 - ( heteroarylo ) pirydyno - 2 - onowi receptora apj do stosowania w leczeniu zaburzeń sercowo-naczyniowych
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
EP3380970B1
(en)
|
2015-11-24 |
2023-01-04 |
Sanford Burnham Prebys Medical Discovery Institute |
Novel azole derivatives as apelin receptor agonist
|
|
EP3383860B1
(en)
|
2015-12-04 |
2021-01-20 |
Bristol-Myers Squibb Company |
Apelin receptor agonists and methods of use
|
|
TW201725203A
(zh)
|
2015-12-16 |
2017-07-16 |
必治妥美雅史谷比公司 |
作為ａｐｊ受體促效劑之雜芳基羥基嘧啶酮
|
|
SG11201808163WA
(en)
|
2016-03-24 |
2018-10-30 |
Bristol Myers Squibb Co |
6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists
|
|
ES2844184T3
(es)
|
2016-06-14 |
2021-07-21 |
Bristol Myers Squibb Co |
4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ
|
|
US10508104B2
(en)
|
2016-06-14 |
2019-12-17 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
|
|
CN110072850B
(zh)
|
2016-10-14 |
2023-07-21 |
百时美施贵宝公司 |
3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
|